Prospective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures.Autism spectrum disorders (ASD) are characterized by social impairments and restricted/stereotyped behaviors and currently affect an estimated 1 in 68 children aged 8 years old.  In this review, we examine the current state of the field for MEG-related biomarkers in ASD. 
MEG
Prospective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures.Autism spectrum disorders (ASD) are characterized by social impairments and restricted/stereotyped behaviors and currently affect an estimated 1 in 68 children aged 8 years old.  In this review, we examine the current state of the field for MEG-related biomarkers in ASD. 
MEG